Literature DB >> 11592410

Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.

F Grams1, H Brandstetter, S D'Alò, D Geppert, H W Krell, H Leinert, V Livi, E Menta, A Oliva, G Zimmermann, F Gram, H Brandstetter, S D'Alò, D Geppert, H W Krell, H Leinert, E Livi VMenta, A Oliva, G Zimmermann.   

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases that have been implicated in various disease processes. Different classes of MMP inhibitors, including hydroxamic acids, phosphinic acids and thiols, have been previously described. Most of these mimic peptides and most likely bind in a similar way to the corresponding peptide substrates. Here we describe pyrimidine-triones as a completely new class of metalloprotease inhibitors. While the pyrimidine-trione template is used as the zinc-chelating moiety, the substituents have been optimized to yield inhibitors comparable in their inhibition efficiency of matrix metalloproteinases to hydroxamic acid derivatives such as batimastat. However, they are much more specific for a small subgroup of MMPs, namely the gelatinases (MMP-2 and MMP-9).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592410     DOI: 10.1515/BC.2001.159

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  22 in total

Review 1.  Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

Authors:  György Dormán; Sándor Cseh; István Hajdú; László Barna; Dénes Kónya; Krisztina Kupai; László Kovács; Péter Ferdinandy
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

3.  Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain.

Authors:  Jennifer Vandooren; Nathalie Geurts; Erik Martens; Philippe E Van den Steen; Steven De Jonghe; Piet Herdewijn; Ghislain Opdenakker
Journal:  World J Biol Chem       Date:  2011-01-26

Review 4.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

6.  A quicker degradation rate is yielded by a novel kind of transgenic silk fibroin consisting of shortened silk fibroin heavy chains fused with matrix metalloproteinase cleavage sites.

Authors:  Guoping Huang; Danfeng Yang; Chunfeng Sun; Jianping Huang; Keping Chen; Chunxia Zhang; Huiqing Chen; Qin Yao
Journal:  J Mater Sci Mater Med       Date:  2014-05-07       Impact factor: 3.896

Review 7.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

8.  Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.

Authors:  Markus-N Kruse; Christoph Becker; Daniel Lottaz; Danny Köhler; Irene Yiallouros; Hans-Willi Krell; Erwin E Sterchi; Walter Stöcker
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

9.  High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.

Authors:  Janelle L Lauer-Fields; Dmitriy Minond; Peter S Chase; Pierre E Baillargeon; S Adrian Saldanha; Roma Stawikowska; Peter Hodder; Gregg B Fields
Journal:  Bioorg Med Chem       Date:  2008-03-06       Impact factor: 3.641

10.  Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group.

Authors:  Etelka Farkas; Yiffat Katz; Sudhakar Bhusare; Reuven Reich; Gerd-Volker Röschenthaler; Martin Königsmann; Eli Breuer
Journal:  J Biol Inorg Chem       Date:  2004-02-05       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.